Your browser doesn't support javascript.
loading
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Novi, Giovanni; Mikulska, Malgorzata; Briano, Federica; Toscanini, Federica; Tazza, Francesco; Uccelli, Antonio; Inglese, Matilde.
Afiliação
  • Novi G; Department of Neuroscience, Ospedale Policlinico San Martino, IRCCS, Genova, Italy.
  • Mikulska M; Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; Ospedale Policlinico San Martino, IRCCS, Genova, Italy.
  • Briano F; Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; Ospedale Policlinico San Martino, IRCCS, Genova, Italy.
  • Toscanini F; Ospedale Policlinico San Martino, IRCCS, Genova, Italy.
  • Tazza F; Ospedale Policlinico San Martino, IRCCS, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy.
  • Uccelli A; Ospedale Policlinico San Martino, IRCCS, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy.
  • Inglese M; Ospedale Policlinico San Martino, IRCCS, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy. Electronic address: m.inglese@unige.it.
Mult Scler Relat Disord ; 42: 102120, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32315980

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Esclerose Múltipla Crônica Progressiva / Anticorpos Monoclonais Humanizados / Fatores Imunológicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Esclerose Múltipla Crônica Progressiva / Anticorpos Monoclonais Humanizados / Fatores Imunológicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article